Moderna, Inc. Quarterly Debt-to-equity in % from Q3 2019 to Q3 2024

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Moderna, Inc. quarterly Debt-to-equity history and growth rate from Q3 2019 to Q3 2024.
  • Moderna, Inc. Debt-to-equity for the quarter ending September 30, 2024 was 32.5 %, a 3.19% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q3 2024 32.5 -1.07 -3.19% Sep 30, 2024
Q2 2024 35.6 +1.31 +3.82% Jun 30, 2024
Q1 2024 34 -4 -10.5% Mar 31, 2024
Q4 2023 32.9 -13.4 -28.9% Dec 31, 2023
Q3 2023 33.5 -21.8 -39.4% Sep 30, 2023
Q2 2023 34.3 -33 -49.1% Jun 30, 2023
Q1 2023 38 -48 -55.8% Mar 31, 2023
Q4 2022 46.3 -67.6 -59.4% Dec 31, 2022
Q3 2022 55.3 -90.5 -62.1% Sep 30, 2022
Q2 2022 67.3 -90.2 -57.3% Jun 30, 2022
Q1 2022 86 -46.7 -35.2% Mar 31, 2022
Q4 2021 114 +36.8 +47.8% Dec 31, 2021
Q3 2021 146 +107 +280% Sep 30, 2021
Q2 2021 157 +133 +542% Jun 30, 2021
Q1 2021 133 +104 +369% Mar 31, 2021
Q4 2020 77 +48.9 +174% Dec 31, 2020
Q3 2020 38.4 +11.8 +44.3% Sep 30, 2020
Q2 2020 24.5 Jun 30, 2020
Q1 2020 28.3 Mar 31, 2020
Q4 2019 28.1 Dec 31, 2019
Q3 2019 26.6 Sep 30, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.